Epirubicin (hydrochloride)

Filters:

Gene Set

Results for "Epirubicin (hydrochloride)_HepG2/C3A": 1001 gene sets

Name
Epirubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
EPIRUBICIN HYDROCHLORIDE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the EPIRUBICIN HYDROCHLORIDE drug from theDGIdb Drug Targets 2026 dataset.
Epirubicin Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Epirubicin from the curated CTD Gene-Chemical Interactions dataset.
Epirubicin Gene Set From DrugBank Drug Targets interacting proteins for the Epirubicin drug from the curated DrugBank Drug Targets dataset.
epirubicin Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term epirubicin in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
Epirubicin-induced leukopenia Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Epirubicin-induced leukopenia phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
Epirubicin Gene Set From HMDB Metabolites of Enzymes interacting proteins for the Epirubicin metabolite from the curated HMDB Metabolites of Enzymes dataset.
Response To Epirubicin Gene Set From DisGeNET Gene-Phenotype Associations genes associated with the phenotype Response To Epirubicin in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) Gene Set From GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Epirubicin-induced leukopenia Gene Set From GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Epirubicin-induced leukopenia phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) Gene Set From GWAS Catalog SNP-Phenotype Associations 2025 genes associated with the Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
EPIRUBICIN Gene Set From DGIdb Drug Targets 2026 interacting proteins for the EPIRUBICIN drug from theDGIdb Drug Targets 2026 dataset.
C3A Gene Set From CCLE Cell Line Gene CNV Profiles genes with high or low copy number in C3A relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
C3A Gene Set From CCLE Cell Line Gene Expression Profiles genes with high or low expression in C3A relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
C3A Gene Set From CCLE Cell Line Gene Mutation Profiles genes mutated in the C3A cell line from the CCLE Cell Line Gene Mutation Profiles dataset.
C3A Gene Set From COSMIC Cell Line Gene CNV Profiles genes with high or low copy number in C3A relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
C3A Gene Set From COSMIC Cell Line Gene Mutation Profiles genes mutated in the C3A cell line from the COSMIC Cell Line Gene Mutation Profiles dataset.
C3A Gene Set From GDSC Cell Line Gene Expression Profiles genes with high or low expression in C3A relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
c3a Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term c3a in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
c3a anaphylatoxin receptor activity Gene Set From GO Molecular Function Annotations 2015 genes performing the c3a anaphylatoxin receptor activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
complement component c3a receptor activity Gene Set From GO Molecular Function Annotations 2015 genes performing the complement component c3a receptor activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
[¹²⁵I]C3a (human) Gene Set From Guide to Pharmacology Chemical Ligands of Receptors receptors of the [¹²⁵I]C3a (human) ligand (chemical) from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
C3a anaphylatoxin chemotactic receptor Gene Set From InterPro Predicted Protein Domain Annotations proteins predicted to have the C3a anaphylatoxin chemotactic receptor protein domain from the InterPro Predicted Protein Domain Annotations dataset.
C3A Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles genes with high or low copy number in C3A relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
C3A Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles genes with high or low expression in C3A relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
C3A Gene Set From Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles genes mutated in the C3A cell line from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
hep-g2/c3a cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores proteins co-occuring with the tissue hep-g2/c3a cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
C3A Gene Set From Sanger Dependency Map Cancer Cell Line Proteomics proteins associated with the cell line C3A from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
complement component C3a binding Gene Set From GO Molecular Function Annotations 2023 genes performing the complement component C3a binding molecular function from the curated GO Molecular Function Annotations 2023 dataset.
complement component C3a receptor activity Gene Set From GO Molecular Function Annotations 2023 genes performing the complement component C3a receptor activity molecular function from the curated GO Molecular Function Annotations 2023 dataset.
complement component C3a binding Gene Set From GO Molecular Function Annotations 2025 genes performing the complement component C3a binding molecular function from the curated GO Molecular Function Annotations 2025 dataset.
complement component C3a receptor activity Gene Set From GO Molecular Function Annotations 2025 genes performing the complement component C3a receptor activity molecular function from the curated GO Molecular Function Annotations 2025 dataset.
Hep-G2/C3A cell Gene Set From TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 proteins co-occuring with the tissue Hep-G2/C3A cell in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
Trametinib (DMSO_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib (DMSO_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clofarabine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clofarabine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Budesonide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Budesonide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entrectinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entrectinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Radotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Radotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vortioxetine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vortioxetine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Amsacrine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Amsacrine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Naproxen_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Naproxen_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ponatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ponatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Econazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Econazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymopentin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymopentin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darolutamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darolutamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clobetasol propionate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clobetasol propionate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexamethasone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexamethasone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cinacalcet_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cinacalcet_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fulvestrant_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fulvestrant_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cyclosporin A_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cyclosporin A_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Malotilate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Malotilate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Decitabine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Decitabine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triamcinolone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triamcinolone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Demeclocycline_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Demeclocycline_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dimethyl fumarate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dimethyl fumarate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Finasteride_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Finasteride_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Torkinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Torkinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Filgotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Filgotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-733_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-733_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flutamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flutamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
γ-Oryzanol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the γ-Oryzanol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sunitinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sunitinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sildenafil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sildenafil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Uridine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Uridine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Salicylic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Salicylic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylprednisolone succinate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylprednisolone succinate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Valdecoxib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Valdecoxib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbamazepine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbamazepine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bendamustine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bendamustine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methylthiouracil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methylthiouracil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erythromycin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erythromycin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Encorafenib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Encorafenib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glycyrrhizic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glycyrrhizic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ligustrazine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ligustrazine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tranilast_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tranilast_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Arbutin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Arbutin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ferulic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ferulic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Infigratinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Infigratinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ribociclib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ribociclib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verteporfin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verteporfin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemetrexed_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemetrexed_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ataluren_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ataluren_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NVP-BHG712_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NVP-BHG712_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abiraterone acetate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abiraterone acetate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brimonidine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brimonidine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trametinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trametinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Apalutamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Apalutamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ritonavir_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ritonavir_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Resveratrol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Resveratrol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ULK-101_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ULK-101_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Terfenadine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Terfenadine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anethole trithione_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anethole trithione_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
OTS514_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the OTS514_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
8-Hydroxyquinoline_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 8-Hydroxyquinoline_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Silodosin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Silodosin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
SBI-0640756_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the SBI-0640756_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
EX229_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the EX229_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Abemaciclib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Abemaciclib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bortezomib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bortezomib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Verapamil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Verapamil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD2858_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD2858_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Digitoxin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Digitoxin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fenofibrate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fenofibrate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Altretamine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Altretamine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetohexamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetohexamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Megestrol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Megestrol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Regorafenib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Regorafenib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Simotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Simotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lucanthone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lucanthone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Orlistat_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Orlistat_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentoxifylline_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentoxifylline_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Menadione_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Menadione_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bexarotene_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bexarotene_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Larotrectinib sulfate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Larotrectinib sulfate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artemether_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artemether_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tazarotene_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tazarotene_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Folic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Folic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ornidazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ornidazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Meloxicam_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Meloxicam_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aprepitant_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aprepitant_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mifepristone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mifepristone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Betamethasone dipropionate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Betamethasone dipropionate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nevirapine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nevirapine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Eplerenone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Eplerenone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trifluridine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trifluridine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Fluorouracil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Fluorouracil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Auranofin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Auranofin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Binimetinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Binimetinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capivasertib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capivasertib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentagastrin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentagastrin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dihydroartemisinin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dihydroartemisinin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Medroxyprogesterone acetate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Medroxyprogesterone acetate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Captopril_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Captopril_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
XRK3F2_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the XRK3F2_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elimusertib hydrochloride_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elimusertib hydrochloride_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cobimetinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cobimetinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolcapone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolcapone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Capmatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Capmatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Voriconazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Voriconazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Asciminib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Asciminib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temsirolimus_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temsirolimus_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Panobinostat_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Panobinostat_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erlotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erlotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DTP3_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DTP3_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Glasdegib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Glasdegib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lipoic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lipoic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Zileuton_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Zileuton_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ipatasertib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ipatasertib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cilostazol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cilostazol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
CP21R7_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the CP21R7_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vemurafenib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vemurafenib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pralsetinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pralsetinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ralimetinib dimesylate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ralimetinib dimesylate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
HI-TOPK-032_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the HI-TOPK-032_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinestrol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinestrol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
9-ING-41_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 9-ING-41_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Minodronic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Minodronic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD1390_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD1390_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ETC-206_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ETC-206_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-3406_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-3406_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ERK5-IN-2_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ERK5-IN-2_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimatoprost_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimatoprost_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Isocorydine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Isocorydine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
IQ 1_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the IQ 1_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-8353_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-8353_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
DT-061_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the DT-061_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Penfluridol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Penfluridol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Thymol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Thymol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Retinoic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Retinoic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LB-100_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LB-100_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Alpelisib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Alpelisib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Volasertib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Volasertib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tucidinostat_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tucidinostat_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dabrafenib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dabrafenib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Trimetrexate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Trimetrexate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Furosemide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Furosemide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Anastrozole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Anastrozole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cepharanthine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cepharanthine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
olaparib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the olaparib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fusidic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fusidic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TAK-901_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the TAK-901_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Darinaparsin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Darinaparsin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allantoin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allantoin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Harringtonine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Harringtonine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PH-797804_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PH-797804_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Delamanid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Delamanid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tubulin inhibitor 6_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tubulin inhibitor 6_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Futibatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Futibatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemcitabine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemcitabine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tadalafil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tadalafil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lonafarnib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lonafarnib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Olanzapine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Olanzapine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Homoharringtonine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Homoharringtonine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ciclopirox_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ciclopirox_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
vincristine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the vincristine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
NG25_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the NG25_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Afatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Afatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
palbociclib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the palbociclib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Everolimus_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Everolimus_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vilanterol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vilanterol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Brivudine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Brivudine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BI-78D3_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BI-78D3_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oleic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oleic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
ML264_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the ML264_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Raltitrexed_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Raltitrexed_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
4EGI-1_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 4EGI-1_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tomivosertib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tomivosertib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Paclitaxel_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Paclitaxel_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belzutifan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belzutifan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sulfisoxazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sulfisoxazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimozide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimozide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vitamin K4_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vitamin K4_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Piroxicam_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Piroxicam_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clotrimazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clotrimazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Relugolix_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Relugolix_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aspirin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aspirin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sapanisertib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sapanisertib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daptomycin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daptomycin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adenosine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adenosine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyurea_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyurea_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Elagolix sodium_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Elagolix sodium_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
PF-06260933_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the PF-06260933_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-7648_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-7648_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
GSK1059615_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the GSK1059615_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vandetanib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vandetanib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bergenin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bergenin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gemfibrozil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gemfibrozil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(S)-Crizotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (S)-Crizotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
18β-Glycyrrhetinic acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 18β-Glycyrrhetinic acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
crizotinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the crizotinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methotrexate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methotrexate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
MK-3903_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the MK-3903_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Saquinavir_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Saquinavir_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Adagrasib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Adagrasib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idoxuridine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idoxuridine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rapamycin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rapamycin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Proglumide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Proglumide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lopinavir_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lopinavir_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Macitentan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Macitentan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Acetazolamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Acetazolamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Roxadustat_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Roxadustat_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Daidzin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Daidzin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diammonium Glycyrrhizinate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diammonium Glycyrrhizinate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaliplatin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaliplatin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fumaric acid_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fumaric acid_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lapatinib ditosylate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lapatinib ditosylate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rosiglitazone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rosiglitazone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Monocrotaline_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Monocrotaline_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AZD-8055_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AZD-8055_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Diphenhydramine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Diphenhydramine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Temuterkib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Temuterkib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Talc_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Talc_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Peretinoin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Peretinoin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dexmedetomidine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dexmedetomidine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Aliskiren_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Aliskiren_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
5-Azacytidine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the 5-Azacytidine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belinostat_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belinostat_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pimitespib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pimitespib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pioglitazone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pioglitazone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ranolazine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ranolazine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Celecoxib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Celecoxib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rifaximin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rifaximin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hydroxyfasudil_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hydroxyfasudil_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY2090314_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY2090314_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sonidegib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sonidegib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hesperidin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hesperidin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Plicamycin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Plicamycin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Oxaprozin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Oxaprozin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
BAY1125976_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the BAY1125976_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tolmetin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tolmetin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
APTO-253_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the APTO-253_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mozavaptan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mozavaptan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gefitinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gefitinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dinaciclib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dinaciclib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Riluzole hydrochloride_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Riluzole hydrochloride_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Baicalin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Baicalin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Allopurinol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Allopurinol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clopidogrel_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clopidogrel_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Triclosan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Triclosan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pemigatinib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pemigatinib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mebendazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mebendazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LJI308_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LJI308_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Posaconazole_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Posaconazole_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ixazomib citrate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ixazomib citrate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vismodegib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vismodegib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
c-Kit-IN-1_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the c-Kit-IN-1_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
venetoclax_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the venetoclax_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sinomenine_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sinomenine_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Drospirenone_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Drospirenone_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bicalutamide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bicalutamide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
AT7519_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the AT7519_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
RMC-6236_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the RMC-6236_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bentamapimod_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bentamapimod_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Busulfan_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Busulfan_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sodium Salicylate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sodium Salicylate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Artesunate_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Artesunate_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Hexylresorcinol_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Hexylresorcinol_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bimiralisib_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bimiralisib_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivermectin_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivermectin_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nimesulide_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nimesulide_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
C3A Gene Set From DGIdb Drug Targets 2026 interacting proteins for the C3A drug from theDGIdb Drug Targets 2026 dataset.
C3A RECEPTOR AGONIST Gene Set From DGIdb Drug Targets 2026 interacting proteins for the C3A RECEPTOR AGONIST drug from theDGIdb Drug Targets 2026 dataset.
[125I]C3A (HUMAN) Gene Set From DGIdb Drug Targets 2026 interacting proteins for the [125I]C3A (HUMAN) drug from theDGIdb Drug Targets 2026 dataset.
hydrastine hydrochloride-7309 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-7309 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-2889 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-2889 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-1740 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-1740 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-6011 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-6011 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
temocapril hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical temocapril hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
adrogolide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical adrogolide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
Tiapamil Hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Tiapamil Hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE Gene Set From DrugBank Drug Targets interacting proteins for the N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE drug from the curated DrugBank Drug Targets dataset.
betaxolol hydrochloride efficacy Gene Set From GAD Gene-Disease Associations genes associated with the disease betaxolol hydrochloride efficacy in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
hydrochloride Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term hydrochloride in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
Serum tamsulosin hydrochloride concentration Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Serum tamsulosin hydrochloride concentration phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BCI-hydrochloride Gene Set From LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BCI-hydrochloride small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset.
Doxorubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.

Harmonizome 3.0

Epirubicin (hydrochloride)_HepG2/C3A Gene Set

Irinotecan (hydrochloride)_HepG2/C3A Gene Set

Methyl aminolevulinate (hydrochloride)_HepG2/C3A Gene Set

Norepinephrine (hydrochloride)_HepG2/C3A Gene Set

Bestatin (hydrochloride)_HepG2/C3A Gene Set

(R)-Verapamil (hydrochloride)_HepG2/C3A Gene Set

Doxorubicin (hydrochloride)_HepG2/C3A Gene Set

Idarubicin (hydrochloride)_HepG2/C3A Gene Set

Cytarabine (hydrochloride)_HepG2/C3A Gene Set

Imiquimod (hydrochloride)_HepG2/C3A Gene Set

Levobupivacaine (hydrochloride)_HepG2/C3A Gene Set

Pexidartinib (hydrochloride)_HepG2/C3A Gene Set

Crizotinib (hydrochloride)_HepG2/C3A Gene Set

Topotecan (hydrochloride)_HepG2/C3A Gene Set

Ivabradine (hydrochloride)_HepG2/C3A Gene Set

Procainamide (hydrochloride)_HepG2/C3A Gene Set

Clonidine (hydrochloride)_HepG2/C3A Gene Set

Ropivacaine (hydrochloride monohydrate)_HepG2/C3A Gene Set

Almonertinib (hydrochloride)_HepG2/C3A Gene Set

Lidocaine (hydrochloride)_HepG2/C3A Gene Set

Cysteamine (hydrochloride)_HepG2/C3A Gene Set

Esmolol (hydrochloride)_HepG2/C3A Gene Set

Pyridoxine (hydrochloride)_HepG2/C3A Gene Set

Tirabrutinib (hydrochloride)_HepG2/C3A Gene Set

Loperamide (hydrochloride)_HepG2/C3A Gene Set

Fedratinib (hydrochloride hydrate)_HepG2/C3A Gene Set

Phenylephrine (hydrochloride)_HepG2/C3A Gene Set

Fingolimod (hydrochloride)_HepG2/C3A Gene Set

Rimonabant (Hydrochloride)_HepG2/C3A Gene Set

Tetracycline (hydrochloride)_HepG2/C3A Gene Set

Dorzolamide (hydrochloride)_HepG2/C3A Gene Set

Estrone sulfate (potassium)_HepG2/C3A Gene Set

Carbidopa (monohydrate)_HepG2/C3A Gene Set

Lactate (calcium)_HepG2/C3A Gene Set

Almonertinib (mesylate)_HepG2/C3A Gene Set

Doxycycline (monohydrate)_HepG2/C3A Gene Set

Phenytoin (sodium)_HepG2/C3A Gene Set

Citalopram (hydrobromide)_HepG2/C3A Gene Set

Berbamine (dihydrochloride)_HepG2/C3A Gene Set

Lumateperone (tosylate)_HepG2/C3A Gene Set

Rutin (trihydrate)_HepG2/C3A Gene Set

Rucaparib (phosphate)_HepG2/C3A Gene Set

Benztropine (mesylate)_HepG2/C3A Gene Set

Erdafitinib _HepG2/C3A Gene Set

Edoxaban (tosylate monohydrate)_HepG2/C3A Gene Set

Perindopril (erbumine)_HepG2/C3A Gene Set

L-Eflornithine (monohydrochloride)_HepG2/C3A Gene Set

Flumatinib (mesylate)_HepG2/C3A Gene Set

Docetaxel (Trihydrate)_HepG2/C3A Gene Set

Fostamatinib (disodium hexahydrate)_HepG2/C3A Gene Set

Sivelestat (sodium tetrahydrate)_HepG2/C3A Gene Set

Palmatine (chloride)_HepG2/C3A Gene Set

Canagliflozin (hemihydrate)_HepG2/C3A Gene Set

Bosentan (hydrate)_HepG2/C3A Gene Set

Osimertinib (mesylate)_HepG2/C3A Gene Set

Atazanavir (sulfate)_HepG2/C3A Gene Set

Vinblastine (sulfate)_HepG2/C3A Gene Set

Ouabain (Octahydrate)_HepG2/C3A Gene Set

Cabozantinib (S-malate)_HepG2/C3A Gene Set

Omeprazole (sodium)_HepG2/C3A Gene Set

LY-2584702 (tosylate salt)_HepG2/C3A Gene Set

Pasireotide (acetate)_HepG2/C3A Gene Set

Pitavastatin (Calcium)_HepG2/C3A Gene Set

Selinexor _HepG2/C3A Gene Set

Fluvoxamine (maleate)_HepG2/C3A Gene Set

Lenalidomide (hemihydrate)_HepG2/C3A Gene Set

Neratinib (maleate)_HepG2/C3A Gene Set

S-Adenosyl-L-methionine (disulfate tosylate)_HepG2/C3A Gene Set

Chlorhexidine (diacetate)_HepG2/C3A Gene Set

Nafamostat (mesylate)_HepG2/C3A Gene Set

Imiquimod (maleate)_HepG2/C3A Gene Set

Niclosamide (olamine)_HepG2/C3A Gene Set

Quinidine (15% dihydroquinidine)_HepG2/C3A Gene Set

Pravastatin (sodium)_HepG2/C3A Gene Set

Azithromycin (hydrate)_HepG2/C3A Gene Set

Goserelin (acetate)_HepG2/C3A Gene Set

Balsalazide (sodium hydrate)_HepG2/C3A Gene Set

Benproperine (phosphate)_HepG2/C3A Gene Set

L-Thyroxine (sodium salt pentahydrate)_HepG2/C3A Gene Set